Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)

NCT01662102 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Follicular Lymphoma

Interventions

DRUG: Zevalin
DRUG: Rituximab

Sponsor

Spectrum Pharmaceuticals, Inc